Beruflich Dokumente
Kultur Dokumente
&
Sleep
1
Stephan Eisenschenk, MD
Department of Neurology
Stephan Eisenschenk, MD
Department of Neurology
NREM
Parasomnia
REM Behavior
Disorder
Nocturnal
Seizures
Psychogenic
Events
Time of
Occurrence
During REM;
Any time (most
latter 2/3 of night common during
first 2 hours and
last 2 hours of
sleep)
Anytime
Memory of
Event
Usually none
Dream recall
None
Stereotypical
Movements
No
No
Yes
No
PSG Findings
Arousal from
delta sleep
XS EMG tone
during REM
sleep
Potentially
epileptic activity
Occur from
awake state
2
NREM Parasomnias
Age of onset
Usually < 10 yo
1-4
Clinical course
Decreasing/disappearing
Movement semiology
Stereotypic
Polymorphic
Attack onset
Attack distribution
2- NREM (65%)
3-4 NREM
Motor Pattern
Duration of attacks
Several minutes
Diagnostic Evaluation
1)
Daylab video EEG (awake only): essentially all normal
2)
Daylab videoEEG (after sleep deprivation): 52.2% abnormal
3)
24 hour videoEEG (daytime and nocturnal): 87% abnormal
3
Stephan Eisenschenk, MD
Department of Neurology
4
Stephan Eisenschenk, MD
Department of Neurology
11
Stephan Eisenschenk, MD
Department of Neurology
%seizures
%sleep
30
20
10
0
stage 1
stage 2
SWS
REM
Herman et al, Neurology 2001;56:1453-9.
Stephan Eisenschenk, MD
Department of Neurology
13
14
Stephan Eisenschenk, MD
Department of Neurology
Sleep Efficiency
Stephan Eisenschenk, MD
Department of Neurology
100
90
80
70
60
50
40
30
20
10
0
Control
Day Seizure
Night Seizure
Before REM
15
*
*
% Sleep
40
30
Control
Day Seizure
Before REM
20
10
0
Stephan Eisenschenk, MD
Department of Neurology
*
1
REM
*
16
Better
QoL
Worse
QoL
55
**
50
***
***
45
***
40
35
All
Undisturbed
Sleep
Disturbed
Sleep
All
Undisturbed Disturbed
Sleep
Sleep
17
20%
10%
NREM Sleep
REM Sleep
Seizure Promoter
Seizure Protector
Synchronized sleep
Desynchronized sleep
18
Stephan Eisenschenk, MD
Department of Neurology
% beginning in sleep
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
*
Awake
P<0.0001
Frontal
Stephan Eisenschenk, MD
Department of Neurology
Asleep
Temporal
Posterior
19
Herman et al, Neurology
2001;
56:1453-9.
80
70
% generalizing
60
50
40
30
20
Awake
Asleep
P<0.0001
10
0
Stephan Eisenschenk, MD
Department of Neurology
frontal
temporal
occipital
20
Herman et al, Neurology 2001;56:1453-9.
21
Stephan Eisenschenk, MD
Department of Neurology
Phenobarbital
Decreases sleep latency, arousals
Increases Stage 2, decreases REM
Restlessness in latter part of night
REM rebound with drug withdrawal
Benzodiazepines
Reduces sleep latency and awakenings
Increases Stage 2, decreases SWS
REM rebound with drug withdrawal
Stephan Eisenschenk, MD
Department of Neurology
23
Carbamazepine
Decreases sleep latency, arousals; improves sleep efficiency
REM unchanged
Increase PLMS
Valproate
Increases SWS
Decreases REM
Phenytoin
Shorten sleep latency
Lamotrigine
Decreased stage shifts and arousals
Increased REM sleep
Topiramate
No sleep studies
Zonisamide
Occasional reports of insomnia
Levetiracetam
Increases stage 2, decreases SWS
24
Stephan Eisenschenk, MD
Department of Neurology